The frequent observation of methylated BMP3 in CC tumor samples but not in matched benign bile duct epithelium suggests that DNA methylation markers are important targets for the development of a critically needed surveillance tool for patients at high risk for CC or a screening test for CC in the general population. This evidence concerns the gene BMP3 and cholangiocarcinoma.